Schaefer EJ - Search Results

1

Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease.

Schaefer EJ, Heaton WH, Wetzel MG, Brewer HB Jr. Schaefer EJ, et al. Arteriosclerosis. 1982 Jan-Feb;2(1):16-26. doi: 10.1161/01.atv.2.1.16. Arteriosclerosis. 1982. PMID: 6800349

2

Metabolism of high-density lipoprotein apolipoproteins in Tangier disease.

Schaefer EJ, Blum CB, Levy RI, Jenkins LL, Alaupovic P, Foster DM, Brewer HB Jr. Schaefer EJ, et al. N Engl J Med. 1978 Oct 26;299(17):905-10. doi: 10.1056/NEJM197810262991701. N Engl J Med. 1978. PMID: 211412

3

The composition and metabolism of high density lipoprotein subfractions.

Schaefer EJ, Foster DM, Jenkins LL, Lindgren FT, Berman M, Levy RI, Brewer HB Jr. Schaefer EJ, et al. Lipids. 1979 May;14(5):511-22. doi: 10.1007/BF02533471. Lipids. 1979. PMID: 222991

4

Familial apolipoprotein A-I and C-III deficiency, variant II.

Schaefer EJ, Ordovas JM, Law SW, Ghiselli G, Kashyap ML, Srivastava LS, Heaton WH, Albers JJ, Connor WE, Lindgren FT, et al. Schaefer EJ, et al. J Lipid Res. 1985 Sep;26(9):1089-101. J Lipid Res. 1985. PMID: 3934306 Free article.

5

Activation of the enzymic activity of hepatic lipase by apolipoprotein A-II. Characterization of a major component of high density lipoprotein as the activating plasma component in vitro.

Jahn CE, Osborne JC Jr, Schaefer EJ, Brewer HB Jr. Jahn CE, et al. Among authors: schaefer ej. Eur J Biochem. 1983 Mar 1;131(1):25-9. doi: 10.1111/j.1432-1033.1983.tb07227.x. Eur J Biochem. 1983. PMID: 6403350 Free article. No abstract available.

6

Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.

Schaefer EJ, Anderson DW, Zech LA, Lindgren FT, Bronzert TB, Rubalcaba EA, Brewer HB Jr. Schaefer EJ, et al. J Lipid Res. 1981 Feb;22(2):217-28. J Lipid Res. 1981. PMID: 6787156 Free article.

7

Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).

Alaupovic P, Schaefer EJ, McConathy WJ, Fesmire JD, Brewer HB Jr. Alaupovic P, et al. Among authors: schaefer ej. Metabolism. 1981 Aug;30(8):805-9. doi: 10.1016/0026-0495(81)90027-5. Metabolism. 1981. PMID: 6790903

8

Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).

Kay LL, Ronan R, Schaefer EJ, Brewer HB Jr. Kay LL, et al. Among authors: schaefer ej. Proc Natl Acad Sci U S A. 1982 Apr;79(8):2485-9. doi: 10.1073/pnas.79.8.2485. Proc Natl Acad Sci U S A. 1982. PMID: 6806810 Free PMC article.

9

Human apolipoprotein A-I and A-II metabolism.

Schaefer EJ, Zech LA, Jenkins LL, Bronzert TJ, Rubalcaba EA, Lindgren FT, Aamodt RL, Brewer HB Jr. Schaefer EJ, et al. J Lipid Res. 1982 Aug;23(6):850-62. J Lipid Res. 1982. PMID: 6813411 Free article.

10

Tangier disease. High density lipoprotein deficiency due to defective metabolism of an abnormal apolipoprotein A-i (ApoA-ITangier).

Schaefer EJ, Kay LL, Zech LA, Brewer HB Jr. Schaefer EJ, et al. J Clin Invest. 1982 Nov;70(5):934-45. doi: 10.1172/jci110705. J Clin Invest. 1982. PMID: 7130397 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

595 results

Search Page